Building a Scientific Platform is one of the most valuable activities in Medical Affairs, but it is rarely the easiest. The biggest challenges often don’t involve the science itself. They’re…
The Common Technical Document (CTD) is the foundation of regulatory submissions worldwide. While many view it as a collection of documents, regulators see it as one integrated story supporting a…
Each August, during National Immunization Awareness Month, we recognize the vital role vaccines play in protecting individuals and communities from infectious diseases. Timely immunizations help safeguard those most at risk,…
Every year, medical communications teams invest significant resources generating high-quality evidence through publications, congress presentations, advisory boards, and clinical research. Yet as that evidence is translated into HCP materials, field…
For pharmaceutical, biotech, and medical device organizations, every review delay can impact campaign timelines, product communications, and stakeholder engagement. The challenge isn’t just reviewing content. It’s doing so efficiently while…
Many sponsors think of regulatory writing as a series of individual deliverables. A protocol. An Investigator’s Brochure. A clinical study report. A briefing document. But health authorities don’t review these…
Today’s scientific ecosystem is more interconnected than ever. Clinical development teams, Medical Affairs, investigators, regulators, advocacy organizations, publication professionals, and other stakeholders all contribute to advancing medical evidence. Yet even…
A publication plan isn’t something you create once and put on a shelf. As clinical milestones shift, data mature, stakeholder priorities evolve, and regional needs emerge, publication strategies must continuously…
Great science deserves to be understood. In today’s fast-paced medical communications environment, effective data visualization is essential for transforming complex findings into insights that resonate with diverse audiences. The right…
